Viral pneumonias account for at least 17% of cases of community-acquir
ed pneumonia in children and in adults. Although patients with viral p
neumonia appear less ill clinically than those with bacterial pneumoni
a, viral pneumonias can be fatal. Antiviral therapy is available for p
neumonias caused by respiratory syncytial virus, influenza A virus, an
d cytomegalovirus. Several vaccines are important tools for the preven
tion of influenza A and B pneumonia.